Part,  Chapter, Paragraph

 1   II,     5.  2.  3    |      Central Europe countries (from 73 to 44 per 100.000), 51%
 2   II,     5.  5.  3    |           studies ranges from 44 to 73 per 100,000, while the incidence
 3   II,     5.  5.  3    |    prevalence increased 3.5-fold to 73 between 1973 and 1993.~Based
 4   II,     5.  5.  3    |         Neurol Neurosurg Psychiatry 73;256-260.~Doll R, Hill AB (
 5   II,     5.  5.  3    |          Eur J Neurol 12 Suppl 1:68-73.~Logroscino G (2005): The
 6   II,     5.  7.  1    | transplantation~2. GFR <60 ml/min/1.73 m2 , with or without kidney
 7   II,     5.  7.  1    |      Description~GFR*~(mL/min per 1.73 m2 )~ICD 9 CM Code~ ~Treatment~ ~
 8   II,     5.  8.  3    |             population sample of 25-73 year old patients from Northern
 9   II,     5.  9.  2    |         were reported living in the 73,880 households screened
10   II,     5.  9.  3    |       explained), hay fever (61 and 73%) and eczema (41 and 50%)
11   II,     6.  3.  5    |           per 100 000) and Malta (2.73 per 100 000) reported the
12   II,     6.  3.  7    |             21 countries. Sweden (2.73 per 100 000), followed by
13   II,     8.  2.  2    |           Ophthalmic Epidemiology 6:73-82.~Kocur I (2004): Fifteen
14   II,     8.  2.  2    |           Health Organization. 1995;73(1):115-21.~WHO (2000): Preventing
15   II,     9.  1.  2    | transposition of great vessels, and 73% of hypoplastic left heart (
16   II,     9.  3.  3    |           minorities. Aids 18 :1867-73.~Dubois-Arber F, Jeannin
17  III,    10.  2.  1(11)|            End-year report 2005. No.73. Saint-Maurice: Institut
18  III,    10.  2.  1    |         were estimated to be around 73 000 (Farrell, 1995; EMCDDA,
19  III,    10.  2.  1    |         Oral Epidemiol 2004; 32: 69-73.~ ~Bourgeois DM, Baehni
20  III,    10.  4.  2    |    collection" (EFSA Journal (2005) 73: 1- 60).~ ~Directive 2003/
21  III,    10.  5.  3    |            Policy Implications (pp. 73-100). Oxford: Oxford University